Polypeptides containing γ-amino acids
AssigneeWisconsin Alumni Research Foundation
InventorsSamuel H. Gellman, Matthew G. Woll, Jonathan R. Lai, Justin Murray
Life of this patent
Estimating the term…
Abstract
Disclosed are polypeptide compounds containing at least one residue comprising a cyclically-constrained γ-amino acid residue. The compounds have the formula where A is a hydrogen, hydroxy, amino- or carboxy-protecting group, Y is a single bond or a prolyl-containing linking group, and X and Y are γ-amino acid residues, provided that one of X or Y is a conformationally-restrained γ-amino acid residue, and “a,” “c,” and “d” are positive integers. The compounds find use as non-enzymatically degradable probes to mimic protein behavior in solution.
Claims26
An unnatural polypeptide compound selected from the group consisting of:
- wherein:
- each Y is independently variable and is selected from the group consisting of a single bond or
- wherein each R3 in Formula (ii) is independently variable and is selected from the group consisting of hydrogen, linear or branched C1-C6-alkyl, alkenyl, or alkynyl;
- mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S;
- mono- or bicyclic aryl-C1-C6-alkyl, and mono- or bicyclic heteroaryl-C1-C6-alkyl;
- each R4 in Formula (ii) is selected from the group of substituents as listed hereinbelow for R1;
- each X and each Z in Formula (i) is independently variable and is selected from the group consisting of γ-amino acid residues, provided that at least one of X or Z is a substituted or unsubstituted cyclically-constrained γ-amino acid residue independently selected from the group consisting of:
- wherein R in Formula (iii), together with the carbons to which it is attached, independently defines a substituted or unsubstituted C5 to C10 cycloalkyl, cycloalkenyl, or heterocycle moiety, the heterocycle moiety having 1, 2, or 3 heteroatoms selected from the group consisting of N, S, and O;
- and further wherein substituents on the cyclically-constrained γ-amino acid residue of Formula (iii) are independently selected from the group consisting of linear or branched C1-C6-alkyl, alkenyl, or alkynyl;
- mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S;
- mono- or bicyclic aryl-C1-C6-alkyl, mono- or bicyclic heteroaryl-C1-C6-alkyl, —(CH2)n+1—OR2, —(CH2)n+1—SR2, —(CH2)n+1—S(═O)—CH2—R2, —(CH2)n+1—S(═O)2—CH2—R2, —(CH2)n+1—NR2R2, —(CH2)n+1—NHC(═O)R2, —(CH2)n+1—NHS(═O)2—CH2—R2, —(CH2)n+1—O—(CH2)m—R1, —(CH2)n+1—S—(CH2)m—R1, —(CH2)n+1—S(═O)—(CH2)m—R1, —(CH2)n+1—S(═O)2—(CH2)m—R1, —(CH2)n+1—NH—(CH2)m—R1, —(CH2)n+1—N—{(CH2)m—R1}2, —(CH2)n+1—NHC(═O)—(CH2)n+1—R1, —(CH2)n+1—NHS(═O)2—(CH2)m—R1;
- —(CH2)n—OR, —(CH2)n—SR2, —(CH2)n—S(═O)—CH2—R2, —(CH2)n—S(═O)2—CH2—R2, —(CH2)n—NR2R2, —(CH2)n—NHC(═O)R2, —(CH2)n—NHS(═O)2—CH2—R2, —(CH2)n—O—(CH2)m—R1, —(CH2)n—S—(CH2)m—R1, —(CH2)n—S(═O)—(CH2)m—R1, —(CH2)n—S(═O)2—(CH2)m—R1, —(CH2)n—NH—(CH2)m—R1, —(CH2)n—N—{(CH2)m—R1}2, —(CH2)n—NHC(═O)—(CH2)m—R1, and —(CH2)n—NHS(═O)2—(CH2)m—R1;
- wherein R2 is independently selected from the group consisting of hydrogen, C1-C6-alkyl, alkenyl, or alkynyl;
- mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S;
- mono- or bicyclic aryl-C1-C6-alkyl, and mono- or bicyclic heteroaryl-C1-C6-alkyl;
- and wherein R1 is selected from the group consisting of hydroxy, C1-C6-alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono- or di-C1-C6-alkylamino, mono- or diarylamino, mono- or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl-C1-C6-alkylamino, carboxylic acid, carboxamide, mono- or di-C1-C6-alkylcarboxamide, mono- or diarylcarboxamide, mono- or diheteroarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide, sulfonic acid, sulfonamide, mono- or di-C1-C6-alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea;
- and mono- di- or tri-substituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6-alkyl, aryl, heteroaryl;
- O-alkylurethane, O-arylurethane, and O-heteroarylurethane, and wherein m is an integer of from 2-6 and n is an integer of from 0-6;
- wherein each “A” of Formula (i) is independently selected from the group consisting of hydrogen, hydroxy, an amino-terminus protecting group, and a carboxy-terminus protecting group;
- wherein each of “a,” “c,” and “d” is an independently variable positive integer;
- and
- salts thereof.
Dependencies are inferred from the claim text.